Cryoport (CYRX) Liabilities and Shareholders Equity (2011 - 2026)

Cryoport (CYRX) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $763.6 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $763.6 million, up 9.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 4.04% YoY), and the FY2025 annual result was $765.0 million, up 8.74% from the prior year.
• Liabilities and Shareholders Equity steadied at $763.6 million in Q1 2026 per CYRX's latest filing, from $765.0 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $1.1 billion in Q1 2022 and troughed at $699.8 million in Q1 2025.
• A 5-year average of $895.0 million and a median of $942.8 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity jumped 31.92% in 2022, then declined 29.87% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.0 billion in 2022, then fell by 7.8% to $957.7 million in 2023, then slipped by 26.55% to $703.5 million in 2024, then rose by 8.74% to $765.0 million in 2025, then retreated by 0.18% to $763.6 million in 2026.
• Business Quant data shows CYRX's Liabilities and Shareholders Equity at $763.6 million in Q1 2026, $765.0 million in Q4 2025, and $774.3 million in Q3 2025.